Hu et al. (2013) used a kinetic model to show that the overexpression of HER2 can explain the presence of oscillations in mitogen-activated protein kinase (MAPK) and PI3K signaling pathways in breast cancer [13]. This evidence concerns the gene ERBB2 and breast cancer.